| Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
|---|
| Outline of Final Research Achievements |
Toward design of artificial peptide ligands by de novo, the interaction between hemagglutinin (HA) and peptides that bind to HA of influenza virus were investigated. Sugar-modified peptide showed the binding to the sugar receptor-binding site, but the peptide could not inhibit endocytosis induced by viral infection. This result suggests that the peptide is not directly inhibited the initial attachment of virus to sugar receptor on cell surface. Several analyses indicate that the sugar-modified peptide has a potential to inhibit membrane fusion after endocytosis. This kind of peptide with inhibition of membrane fusion is an unique activity, suggesting that it is useful for designing of peptide ligands with novel mechanism of inhibition for viral infection.
|
